Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. - Wikidata - wikimedia - TriplyDB

Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

http://www.wikidata.org/entity/Q37700035

about

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis)Molecular mechanisms of subretinal fibrosis in age-related macular degeneration.Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.Retinal microangiopathy in a mouse model of inducible mural cell loss.APOPTOSIS AND ANGIOFIBROSIS IN DIABETIC TRACTIONAL MEMBRANES AFTER VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION: Results of a Prospective Trial. Report No. 2.Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.Sustained and targeted episcleral delivery of celecoxib in a rabbit model of retinal and choroidal neovascularization

P2860

Q24187858-4BBC0022-FDFD-4EEC-9538-05323E6233E1 Q35027435-5F1327A4-FB9D-48B6-8396-ED4AAF414DFD Q35577823-1AD967C4-E96A-4E1F-ADC1-27D26FA16A76 Q35717962-7A5D1834-AA16-4E6F-A3AE-8386EF6B0705 Q40196662-9A8ADD68-C1A3-4832-B267-DEE57CA698D1 Q41816335-4610FCE1-5FFA-4A22-867C-6074493F5498 Q46387723-25BB49B5-558B-4723-B7A3-03E4E458894E Q47300238-05827EE8-427C-489F-9245-8032088465F9 Q47710677-EF10B3E1-4C4E-4EDA-9B8D-2EB53317F0B3 Q54942391-9C91EBA7-CB4C-43F0-B4CC-2BD11D183BD5 Q58794549-C54F6C78-AA21-4FE6-A719-E97A80676D87

P2860

Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

http://www.wikidata.org/entity/Q37700035

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@en

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@nl

type

label

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@en

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@nl

prefLabel

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@en

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@nl

P1433

Q37700035-DA75927D-8049-4FF1-99EB-94F751095C10

P1476

Q37700035-37016A24-AF9D-4391-9953-AC8517AA5B26

P2093

Q37700035-01294404-2D65-410D-BED0-D8E6F3C8548D

Q37700035-1562241E-6EF5-4278-9E60-789FF6CFF7B9

Q37700035-2990BF77-ABC0-4FFB-9437-FEE4A052297A

Q37700035-5A108DE5-E1BA-4762-9D38-0FBF16D9B9F8

Q37700035-6CA899F1-4F59-4FFF-97F2-BBAA76B8CA87

Q37700035-9C14B443-BE91-48E0-963C-C346F7598639

Q37700035-D447A7B9-9655-4F35-9C67-962F90D8DB67

P2860

Q37700035-03715970-BE64-44EB-AB90-662E91435B29

Q37700035-0484D7CB-CF3A-4009-85BF-21EFCE6AD8BD

Q37700035-04C015C2-5E38-4540-B4FF-55EAF71A494B

Q37700035-09142C75-CA0A-4599-8653-D4157CC0B775

Q37700035-09F48E16-2EFF-4524-93AF-55A54D6CC7D5

Q37700035-0F2E2BC0-785D-46BD-9995-E95274ED6E33

Q37700035-144097FE-5316-4ECB-B2FE-1685CBE370E1

Q37700035-1EC4F5AE-3EC1-4163-B179-CEFBC61EC64B

Q37700035-24F2DFFB-BC6A-4C5C-8429-9D10EBFEC4F6

Q37700035-277A2BCC-AE47-400C-A12A-4B53F9CE56ED

P304

Q37700035-D0A3E5BD-BF5D-4C41-B121-8E2BCE5AA1A7

P31

Q37700035-2E795CF2-08B9-45D3-B97B-A6E87ED61FB6

P356

Q37700035-243736D5-80A3-4039-8D41-B023526C5E82

P407

Q37700035-7975E348-2C2F-46EF-A953-705E39AD1322

P433

Q37700035-2AD1ACC9-65C5-4044-B8D0-2B907C3AC884

P478

Q37700035-EC324AD4-41C6-45E4-8964-006811B3B22C

P50

Q37700035-A0404E30-E15B-4183-80B4-4CB9E455F371

Q37700035-F39F850F-EF02-478F-8243-D26525428E45

P577

Q37700035-20876CCF-77F2-4F77-BF4D-CC80E606ED5E

P5875

Q37700035-1F32B1AB-2C93-4D6E-A276-615DE971156E

P698

Q37700035-1F817122-BAD9-4921-9AC7-6061856A7218

P921

Q37700035-B2AF9446-DA42-476D-B2C0-B77D6860E507

P932

Q37700035-907BD395-5915-44E8-90ED-FF179A10E704

P356

ARCHOPHTHALMOL.2012.1611

P1433

JAMA Ophthalmology

P1476

Angiofibrotic response to vasc ...... inal detachment: report no. 1.

@en

P2093

Christine Spee

http://www.w3.org/2001/XMLSchema#string

David R Hinton

http://www.w3.org/2001/XMLSchema#string

Dean Eliott

http://www.w3.org/2001/XMLSchema#string

Hani Salehi-Had

http://www.w3.org/2001/XMLSchema#string

Laurie Dustin

http://www.w3.org/2001/XMLSchema#string

Michael Javaheri

http://www.w3.org/2001/XMLSchema#string

Shikun He

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy

The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

Alterations in the intraocular cytokine milieu after intravitreal bevacizumab.

Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair

Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

P304

1127-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHTHALMOL.2012.1611

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230830132

http://www.w3.org/2001/XMLSchema#string

P698

22965588

http://www.w3.org/2001/XMLSchema#string

P921

P932

3984910

http://www.w3.org/2001/XMLSchema#string